文献速递免疫规划慢病防控与筛查

人乳头瘤病毒疫苗接种与自身免疫性疾病风险:系统综述与荟萃分析

Human papillomavirus vaccination and the risk of autoimmune disorders: A systematic review and meta-analysis.
PubMed 文献 · Vaccine · 2019-04-26

该系统综述与荟萃分析检索EMBASE和PubMed截至2018年6月的文献,纳入20项研究(12项队列、6项病例对照、2项随机对照试验),涉及超过169,000例自身免疫性疾病事件。结果显示HPV疫苗接种与后续自身免疫性疾病风险不相关(OR=1.003,95%CI 0.95-1.06),在有既往自身免疫性疾病者中OR=0.82(95%CI 0.7-0.96)。

要点

  • HPV疫苗接种与自身免疫性疾病风险无关联(OR=1.003,95%CI 0.95-1.06)。
  • 有既往自身免疫性疾病者接种后风险未升高(OR=0.82,95%CI 0.7-0.96)。
  • 多数按部位或类型分组的亚组分析结果与总体一致。

核心结论

  • 未发现HPV疫苗接种与自身免疫性疾病风险相关的证据。

研究设计与样本

  • 系统综述与荟萃分析,检索EMBASE和PubMed截至2018年6月的文献。
  • 纳入20项研究:12项队列研究、6项病例对照研究、2项随机对照试验,涉及超过169,000例自身免疫性疾病事件。
  • 采用固定或随机效应模型估计总体相对风险。

主要发现

  • HPV疫苗接种与后续自身免疫性疾病风险不相关(OR=1.003,95%CI 0.95-1.06)。
  • 在有既往自身免疫性疾病者中,OR=0.82(95%CI 0.7-0.96)。
  • 多数基于自身免疫性疾病部位或类型的亚组分析结果与总体结果一致。

临床怎么用

  • 可为HPV疫苗接种与自身免疫性疾病风险的获益-风险评估提供参考。
  • 对有既往自身免疫性疾病者,接种HPV疫苗未显示风险升高。

局限性

  • 针对个别自身免疫性疾病的估计数量较少,需更大规模观察性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Human papillomavirus (HPV) vaccination has been proven to effectively protect against HPV infection and infection-associated cancer. However, there are concerns about the relationship between HPV vaccination and the risk of autoimmune disorders (ADs). Therefore, we performed a systematic review and meta-analysis to comprehensively evaluate the relationship between HPV vaccination and ADs risk. METHODS: To identify relevant studies, we conducted a systematic search in EMBASE and PubMed databases of scientific articles published through June 2018. Fixed or random effects models were adopted to estimate overall relative risk. RESULTS: In total, 20 studies (12 cohort studies, 6 case-control studies, and 2 randomized controlled trials) involving more than 169,000 AD events were included in our meta-analysis. Our results show that HPV vaccination was not associated with an increased risk of subsequent ADs (odds ratio [OR] = 1.003, 95% confidence interval (CI): 0.95-1.06), particularly among those with a prior ADs (OR = 0.82, 95% CI: 0.7-0.96). Most of the subgroup analysis results based on the location or type of ADs were consistent with the overall results. CONCLUSION: No evidence of an association between HPV vaccination and ADs was found. Given the low number of estimates for individual AD, additional and larger observational studies are needed to verify our findings.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Jiang HY, Shi YD, Zhang X, et al. Human papillomavirus vaccination and the risk of autoimmune disorders: A systematic review and meta-analysis. Vaccine. 2019. PMID: 31036452. doi:10.1016/j.vaccine.2019.04.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。